Anorexia nervosa. Current perspectives in research.
This article is a thorough update of drug treatment studies and basic research. In their presentation of drug interventions, the authors discuss the efficacy of such psychotropic medications as neuroleptics, tricyclic antidepressants, lithium carbonate, cyproheptadine, and delta 9-tetrahydrocannabinol. An overview of new research perspectives on two new anorectogenic substances--AP, isolated from the urine of "hypothalamic" anorectics, and satietin, purified from normal serum--is presented.
D000856:Anorexia Nervosa / Q000188:drug therapy* / Q000503:physiopathology; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001067:Appetite Depressants; D003533:Cyproheptadine / Q000627:therapeutic use; D013759:Dronabinol / Q000627:therapeutic use; D006020:Glycopeptides / Q000502:physiology; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D008094:Lithium / Q000627:therapeutic use; D016651:Lithium Carbonate; D010455:Peptides / Q000502:physiology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012106:Research
D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D001067:Appetite Depressants; D006020:Glycopeptides; D010455:Peptides; D011619:Psychotropic Drugs; D016651:Lithium Carbonate; D003533:Cyproheptadine; C035102:satietin; D013759:Dronabinol; D008094:Lithium